Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India · Delayed Price · Currency is INR 2,032.80
+2.30 (0.11%)
Oct 31, 2025, 3:30 PM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 154.54 billion as of October 31, 2025. Its market cap has increased by 6.67% in one year.
Market Cap
154.54B
Enterprise Value
146.67B
Revenue
19.89B
Ranking
n/a
PE Ratio
27.35
Stock Price
2,032.80
Market Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 154.54B, an increase of 2,760,024.65%. That is a compound annual growth rate of 53.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 154.54B | -18.72% |
| Dec 31, 2024 | 190.12B | 84.60% |
| Dec 29, 2023 | 102.99B | 90.47% |
| Dec 30, 2022 | 54.07B | -16.82% |
| Dec 31, 2021 | 65.01B | 69.50% |
| Dec 31, 2020 | 38.35B | 68.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.06T |
| Divi's Laboratories | 1.79T |
| Cipla | 1.24T |
| Apollo Hospitals Enterprise | 1.12T |
| Zydus Lifesciences | 992.30B |
| Mankind Pharma | 984.02B |
| Fortis Healthcare | 772.36B |
| Alkem Laboratories | 658.38B |